Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma
在微小残留病灶（MRD）检测时代，自体干细胞移植是否不再“充分”和“安全”？——根据美法仑剂量对多发性骨髓瘤患者自体干细胞移植疗效的影响
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01437-z
Mirgh, Sumeet; Goel, Arti; Punatar, Sachin; Gokarn, Anant; Jindal, Nishant; Chichra, Akanksha; Nayak, Lingaraj; Bain, Gourav; Nashikkar, Chaitali; Mahajan, Priyanka; Deval, Kalpashree; Khan, Ajmat; Tembhare, Prashant; Patkar, Nikhil; Rajpal, Sweta; Chatterjee, Gaurav; Kannan, Sadhana; Mathew, Libin; Subramanian, Papagudi; Bagal, Bhausaheb; Khattry, Navin
